YourLawyer.com 1-800-LAW-INFO (1-800-529-4636)
DEFECTIVE DRUGS
Home » Defective Drugs
Parker Waichman Alonso LLP is a leader in a defective drug litigation. We are currently evaluating cases involving the prescription drugs listed below. Please click on a specific drug or fill out the form at the right for a free case evaluation by a qualified attorney.
Defective Drugs
Defective Drugs NewsRSS Feed
Migraine Meds Linked to Potentially Fatal Serotonin Syndrome
May 16, 2008 | Parker Waichman Alonso LLP
Triptans, a class of medications used to treat migraines that includes Imitrex, Zomig and others, can cause serotonin syndrome. Serotonin...
Dennis Quaid Tells Congress Victims of Defective Drugs Must be Able to Sue
May 16, 2008 | Parker Waichman Alonso LLP
On Wednesday, actor Dennis Quaid urged the U.S. Congress to preserve patients' rights to sue manufacturers for injuries from defective drugs as he...
Trasylol Gone for Good
May 15, 2008 | Parker Waichman Alonso LLP
Trasylol is being removed from the market for good. Bayer AG had suspended marketing of Trasylol, a drug used to prevent bleeding during heart...
In Wake of Baxter Heparin Recall, Overdose Fears Grow
May 15, 2008 | Parker Waichman Alonso LLP
The recent heparin safety problems have spawned even more concerns about the drug. Baxter International's decision to suspend heparin...
Lawmakers Want More FDA Oversight of Imported Medical Devices and Cosmetics
May 15, 2008 | Parker Waichman Alonso LLP
Democratic lawmakers say the US Food and Drug Administration (FDA) has insufficient funding and power to maintain appropriate oversight and...
FDA Head Faces Reality, Asks Congress for More Funding
May 15, 2008 | Parker Waichman Alonso LLP
Beleaguered Food and Drug Commissioner (FDA) Dr. Andrew C. von Eschenbach has finally written Congress saying the FDA needs an immediate $275 million...
Politics Take Precedent in Heparin Probe
May 14, 2008 | Parker Waichman Alonso LLP
Tainted heparin has killed at least 81 people in the US, and sickened scores more here and in Germany. Yet, the heparin investigation is being...
Beta Blockers Increase Surgery Risk
May 14, 2008 | Parker Waichman Alonso LLP
A new study on the effects of beta blockers and surgical procedures reveals that patients given a beta blocker—beta blockers are a type of...
Definity, Optison Black Box Warning Revised
May 14, 2008 | Parker Waichman Alonso LLP
The Food & Drug Administration (FDA) is watering down its warning about the possible risks of Definity and Optison, micro-bubble contrast agents...
Report Detailed Thimerosal Cover-up
May 14, 2008 | Parker Waichman Alonso LLP
In 2005, Robert F. Kennedy, Jr. published a lengthy examination of the history of Eli Lilly´s deadly mercury compound, thimerosal, in vaccines...
"Disease Mongering" Behind Blockbuster Requip Sales
May 14, 2008 | Parker Waichman Alonso LLP
Restless Legs Syndrome (RLS) is a relatively new term that has become somewhat ubiquitous following a multi-million dollar ad campaign spearheaded by...
Senate Guts Bill to Regulate Industry Gifts to Doctors
May 14, 2008 | Parker Waichman Alonso LLP
A Senate bill under revision would require drug makers and medical device makers to publicly report gifts over $500 annually to doctors; the previous...
Defective Drugs
